BI 44370 TA in Acute Migraine Attack

PHASE2CompletedINTERVENTIONAL
Enrollment

416

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

May 31, 2009

Conditions
Migraine Disorders
Interventions
DRUG

BI 44370 TA Low Dose

DRUG

Eletriptan

DRUG

Placebo

DRUG

BI 44370 TA Medium Dose

Trial Locations (52)

Unknown

1246.4.32004 Boehringer Ingelheim Investigational Site, Antwerp

1246.4.32005 Boehringer Ingelheim Investigational Site, Brussels

1246.4.32006 Boehringer Ingelheim Investigational Site, Charleroi

1246.4.32001 Boehringer Ingelheim Investigational Site, Ghent

1246.4.32002 Boehringer Ingelheim Investigational Site, Hasselt

1246.4.32009 Boehringer Ingelheim Investigational Site, Leuven

1246.4.32007 Boehringer Ingelheim Investigational Site, Liège

1246.4.32008 Boehringer Ingelheim Investigational Site, Montegnée

1246.4.34004 Boehringer Ingelheim Investigational Site, Oviedo

1246.4.3307A Boehringer Ingelheim Investigational Site, Clermont-Ferrand

1246.4.3307B Boehringer Ingelheim Investigational Site, Clermont-Ferrand

1246.4.3303A Boehringer Ingelheim Investigational Site, Lille

1246.4.3301A Boehringer Ingelheim Investigational Site, Nice

1246.4.3301B Boehringer Ingelheim Investigational Site, Nice

1246.4.3305B Boehringer Ingelheim Investigational Site, Paris

1246.4.3304A Boehringer Ingelheim Investigational Site, Rouen

1246.4.3304B Boehringer Ingelheim Investigational Site, Rouen

1246.4.3302A Boehringer Ingelheim Investigational Site, Toulouse

1246.4.3302B Boehringer Ingelheim Investigational Site, Toulouse

1246.4.49002 Boehringer Ingelheim Investigational Site, Berlin

1246.4.49003 Boehringer Ingelheim Investigational Site, Erkelenz

1246.4.49001 Boehringer Ingelheim Investigational Site, Essen

1246.4.49006 Boehringer Ingelheim Investigational Site, Göttingen

1246.4.49004 Boehringer Ingelheim Investigational Site, Grevenbroich

1246.4.49011 Boehringer Ingelheim Investigational Site, Hüttenberg

1246.4.49007 Boehringer Ingelheim Investigational Site, Koenigstein Im Taurus

1246.4.49008 Boehringer Ingelheim Investigational Site, Munich

1246.4.49009 Boehringer Ingelheim Investigational Site, Munich

1246.4.49010 Boehringer Ingelheim Investigational Site, Münster

1246.4.39005 Boehringer Ingelheim Investigational Site, Bologna

1246.4.39006 Boehringer Ingelheim Investigational Site, Catania

1246.4.39001 Boehringer Ingelheim Investigational Site, Milan

1246.4.39004 Boehringer Ingelheim Investigational Site, Milan

1246.4.39003 Boehringer Ingelheim Investigational Site, Roma

1246.4.39002 Boehringer Ingelheim Investigational Site, Torino

1246.4.31001 Boehringer Ingelheim Investigational Site, 's-Hertogenbosch

1246.4.31004 Boehringer Ingelheim Investigational Site, Amsterdam

1246.4.31003 Boehringer Ingelheim Investigational Site, Blaricum

1246.4.31002 Boehringer Ingelheim Investigational Site, Breda

1246.4.31005 Boehringer Ingelheim Investigational Site, Nijmegen

1246.4.31006 Boehringer Ingelheim Investigational Site, Zwolle

1246.4.34002 Boehringer Ingelheim Investigational Site, Barcelona

1246.4.34005 Boehringer Ingelheim Investigational Site, Santiago de Compostela

1246.4.34001 Boehringer Ingelheim Investigational Site, Valencia

1246.4.46001 Boehringer Ingelheim Investigational Site, Gothenburg

1246.4.46004 Boehringer Ingelheim Investigational Site, Linköping

1246.4.46005 Boehringer Ingelheim Investigational Site, Stockholm

1246.4.46002 Boehringer Ingelheim Investigational Site, Vällingby

1246.4.44013 Boehringer Ingelheim Investigational Site, Liverpool

1246.4.44001 Boehringer Ingelheim Investigational Site, Oxford

1246.4.44003 Boehringer Ingelheim Investigational Site, Plymouth

1246.4.44007 Boehringer Ingelheim Investigational Site, Whitechapel, London

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY